This test requires a blood draw, so please ensure you can refer to a phlebotomist in the clients area before you order this test.
Elispot looks at the T cell response and IGG/IGM looks at B cells/Antibodies.
Some people don't produce antibodies and have a more active T cell response.
In an ideal world to assess an infection, a practitioner should look at both sides of the immune system response, in other words, Eli-spot for the T cells/cellular response and IGG/IGM for humoral/B cell/antibody response.
To check for an active infection with the T cells, the Elispot is recommended.
The Chlamydia Pneumoniae Elispot-LTT test is deisgned to detect the intracellular bacterium that causes many neurological and musculoskeletal diseases, including bronchitis and sinusitis.
Chlamydia is an intracellular bacterium, which causes many neurological and musculoskeletal diseases. There are 2 different sub-species of Chlamydia: Chlamydia pneumoniae and Chlamydia trachomatis.
Chlamydia are a family of wide-branched, round-shaped bacteria, which—depending on their sub-groups—can cause various illnesses, from pneumonia to atherosclerosis, and possibly even heart attacks.. Chlamydia bacterium need cells of other organisms to survive and reproduce itself.
Chlamydia pneumoniae is widespread and can cause bronchial infections (bronchitis) and infections of the paranasal sinuses (sinusitis). It can cause lung infections (so called atypical pneumonia), which usually has a mild progression. Chlamydia pneumoniae can be found for example in following illnesses: Rheumatoid arthritis, Fibromyalgia, Multiple Sclerosis, Dementia, Parkinsonism, ALS, ADHS, ADS, Autism and many other diseases/syndromes.
Chlamydia pneumoniae infection in humans takes place mainly by small droplet transmission and has a very high degree of penetration. The Elispot-LTT for Chlamydia pneumoniae shows the actual T-cellular activity of the infection. This information makes it easier to diagnose Chlamydia infections and can also be used to check the success of a course of treatment.
Indication:
- to diagnose an active Chlamydia infection
- to determine the duration of therapy
- to monitor treatment results after a Lyme therapy
Chlamydia infections can be treated with antibodies.
Practical
ACD/CPDA
This sample requires a blood draw